Pulmatrix: Eva Jack named chief business officer
Ms. Jack most recently served as Managing Director at MedImmune Ventures, the corporate venture fund of MedImmune, LLC, which included serving as a board member or board observer for several portfolio companies.
Ms. Jack initially joined MedImmune’s business development group serving as Director and Associate Director, completing numerous in-licensing and out-licensing transactions.
Prior to her tenure at MedImmune, Ms. Jack held various senior leadership positions at Intel Corporation, including Senior Manager of Strategic Investments. ■